ECSEL 2014 IA ´InForMed´ SILEX
| Reference number | |
| Coordinator | Silex Microsystems AB |
| Funding from Vinnova | SEK 5 031 778 |
| Project duration | June 2015 - September 2018 |
| Status | Completed |
| Venture | ECSEL |
Important results from the project
The goal of the InForMed project is to set-up an integrated pilot line for medical devices, which will enable transfer of small scale project, for example successful PhD research projects, into pilot production. This will bridge the gap between academic research and industry and promote a European growth within the market. To solve and ease this transfer process between different partners, systems and procedures have been implemented, a New Product Introduction (NPI) process. This is a tool that provides predictable, reliable and data driven path to high yielding volume production.
Expected long term effects
Silex has successfully demonstrated a product transfer from one production line to another using the methodology dictated by the new product development process, NPI. For this purpose, we have chosen an existing product to use a test vehicle during the transfer from the 150 mm line to the 200 mm line. The transfer product came out with Cpk values similar to the original process and the end customer has accepted the part as a direct replacement to the original part.
Approach and implementation
Silex executed and evaluated multiple short-loop experiments and executed qualification batches to qualify and validate a TSV / 3D polymer medical MEMS product that has the same form, fit and function irrespective of whether it is produced on 150 mm or 200 mm lines. The data of Cpk differences between the two production lines was evaluated. The other success factor is how fast the transfer is. This is challenging to measure since no reference data to compare exists.